Overview

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to monitor long-term safety and tolerability of iloprost aerosol inhalation therapy in patients suffering from pulmonary hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Iloprost